Human Coagulation Factor Ⅷ (Hunan Ziguang Huhan Nanyue Pharmaceutical)

人凝血因子Ⅷ（南岳生物制药）

Report date: 2026/03/03 17:14:37

Base Information

Drug NameHuman Coagulation Factor Ⅷ (Hunan Ziguang Huhan Nanyue Pharmaceutical)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Non-recombinant coagulation factorBiologics > Blood components > Non-recombinant coagulation factor
Mechanisms of ActionCoagulation factor VIII replacementsCoagulation factor X stimulants
TargetsCoagulation factor X
Therapy Area/IndicationsHemophilia A
Global Approved IndicationsHemophilia A
Approved Indications in ChinaHemophilia A
Original Approved Country/TerritoryMainland China
Original Approved Date2021/04/30
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesHunan Ziguang Huhan Nanyue Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHunan Ziguang Huhan Nanyue Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHemophilia A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A